Sports

Indonesia approves Merck’s COVID-19 capsule for emergency use

FILE PHOTO: An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS

FILE PHOTO: An experimental COVID-19 therapy capsule known as molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen on this undated handout photograph launched by Merck & Co Inc and obtained by Reuters Could 17, 2021. Merck & Co Inc/Handout by way of REUTERS

JAKARTA — Indonesia has authorised Merck & Co Inc’s COVID-19 antiviral capsule molnupiravir for emergency use, the nation’s meals and drug company stated in an announcement.

A batch of 400,000 drugs had arrived in Indonesia, well being minister Budi Gunadi Sadikin stated this week. The capsule was collectively developed by U.S.-based Merck and Ridgeback Biotherapeutics.



Related Articles

Back to top button